Monitoring Pluripotency Dynamics in ESCs
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : University of Cambridge
Other organizations : Medical Research Council, Wellcome/MRC Cambridge Stem Cell Institute
Protocol cited in 1 other protocol
Variable analysis
- Passage number: The ESCs were used between passage 15 and passage 25
- Rex1 expression in the cells (monitored by GFP signal analysis using flow cytometry)
- Culture conditions: ESCs were cultured on 0.1% gelatin at all times in 2i medium (N2B27 medium supplemented with MEK inhibitor, GSK3 inhibitor, and Leukemia inhibitory factor (LIF))
- Priming/differentiation protocol: ESCs were passaged and seeded directly into N2B27 medium at a concentration of 4E5 cells/mL
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!